Shear wave elastography differentiates myelofibrosis from essential thrombocytopenia and polycythemia vera and may help diagnose myeloproliferative neoplasms.
Insights on how physicians can find work-life balance, weighing work life and personal lifestyle to ensure an excellent quality of life for themselves.
Using NGS in prognostic assessments enhances myelofibrosis prognosis and survival estimates, representing a step toward personalized medicine in myelofibrosis.
Myeloid-derived suppressor cells are increased in the circulation and in the spleen of patients with primary myelofibrosis and may be new therapeutic targets.
The first study to compare national myelofibrosis outcomes with a large minority cohort illustrates links between age, gender, and ethnicity and worse survival.